Analyst: Expect prasugrel OK by end of April-WEB ONLY
Eli Lilly and Co. should win regulatory approval for its blood-thinner prasugrel by the end of the month, according to one Wall Street analyst. Dr. Tim Anderson, an analyst at Sanford C. Bernstein & Co., made the prediction in a note to investors on Tuesday. He added that Wall Street expects prasugrel to receive full approval, despite being dogged […]